A strategy to pioneer key agent(s) in Cephalotaxus alkaloids against pan-cancer via filtering methodology based on integrated pharmacology

J Transl Med. 2024 Mar 10;22(1):262. doi: 10.1186/s12967-024-05059-0.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alkaloids* / pharmacology
  • Harringtonines* / pharmacology
  • Humans
  • Neoplasms* / drug therapy

Substances

  • Harringtonines
  • Alkaloids